ZyVersa Therapeutics, Inc
West Conshohocken, PA 19428
754-231-1688
At a Glance
- Headquarters
- West Conshohocken, PA
About
ZyVersa Therapeutics, Inc. is a clinical-stage specialty biopharmaceutical company developing first-in-class drugs for inflammatory and renal diseases. It leverages two proprietary platforms: an inflammasome ASC inhibitor (IC 100) for inflammatory conditions and a cholesterol efflux mediator (VAR 200) for kidney diseases.